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Abstract Targeting gene vectors to human airway epithelial
cells may help to overcome the current inefficiency of gene
transfer as the major problem confronting cystic fibrosis gene
therapy. To elucidate novel ligands targeting abundant, apically
located receptors on airway epithelial cells, a phage display
library was screened for peptides binding with high affinity to
such cells. This screening yielded a selectively enriched amino
acid sequence, Thr-His-Ala-Leu-Trp-His-Thr (THALWHT).
Subsequent binding studies confirmed that THALWHT-display-
ing phages bound much stronger than phages displaying control
peptides to human airway epithelial cells. In contrast, no
significant binding differences were observed on a variety of
non-airway-derived human cell lines suggesting selective binding
of the THALWHT motif to airway epithelia. Confocal
microscopy of such cells after exposure to labelled synthetic
THALWHT peptide indicated that its binding is followed by
specific internalisation via endocytosis. A synthetic peptide
comprising a cyclic CTHALWHTC domain and a DNA binding
moiety enabled efficient targeted gene delivery into human
airway epithelial cells. Competition assays with free THAL-
WHT peptide confirmed the specificity of gene delivery. Thus,
the THALWHT motif may prove a useful targeting moiety for
both non-viral and viral gene therapy vectors. ß 2001 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Progress in the ¢eld of cystic ¢brosis gene therapy has been
hampered by low gene transfer e⁄cacy [1,2], thus the develop-
ment of vectors allowing more e⁄cient gene delivery has be-
come a predominant research strategy in this ¢eld. The lack of
cellular receptors that may permit high-a⁄nity binding to the
apical surface of human airway epithelial cells appears to be
the main reason for the ine⁄ciency of adenoviral vectors used
in recent clinical trials [3^7]. To circumvent this problem lung-
targeting from the vascular side has been suggested [2,8]. The
construction of novel vectors to include targeting domains
binding with high a⁄nity to abundant, apically located recep-
tors on airway epithelial cells is another promising approach
to overcome this drawback. Non-viral vectors avoid some
crucial problems inherent to viral vectors [9,10] and are usable
in combination with any given plasmid DNA, thus allowing
fast and £exible adaptation to a particular gene transfer re-
quirement. However, they have not yet reached the gene
transfer e⁄cacy of the best viral vectors and targeted delivery
is an important approach towards their improvement. Non-
viral systems also provide an excellent means for the rapid
testing of a particular targeting moiety with respect to its
suitability for incorporation into viral vectors. Several candi-
date moieties for the targeting of human airway epithelia,
including the surfactant protein A receptor [11] and monoclo-
nal antibodies [12] have been investigated. Our group has been
developing synthetic peptides comprising a cell surface recep-
tor-targeting domain and a cationic DNA binding moiety as
novel non-viral vectors [13^17]. Following our recent identi-
¢cation of a peptide which binds to K9L1-integrin, a receptor
abundant throughout the human airway epithelia [18,19], we
have developed non-viral vectors targeting this integrin [17].
Here we report the isolation of a novel peptide from a phage
display library screened for binding to a human airway epi-
thelial cell line and describe its use for e⁄cient and selective
gene delivery into human airway epithelial cells. We anticipate
that these peptides may be used as targeting moieties of di¡er-
ent non-viral vectors and may also be linked to or incorpo-
rated into the coat of viral vectors [20^26] to allow selective
infection of target cells.
2. Materials and methods
2.1. Cell lines and synthetic peptides
The human cell lines 16HBE14o3 (bronchial epithelium-derived)
and HTEo3 (tracheal epithelium-derived) were maintained in Eagle’s
minimal essential medium (MEM) with L-glutamine (Sigma, Poole)
containing 10% foetal calf serum (FCS), penicillin and streptomycin
(100 U/ml of each). The human cell lines CaCo2 (colon adenocarci-
noma), HeLa (cervix adenocarcinoma), SW480 (colorectal adenocar-
cinoma) and HUH-7 (hepatoma) were grown in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) with 10% FCS (HeLa, SW480, HUH-7) or
20% FCS (CaCo2) and penicillin/streptomycin (100 U/ml of each).
Mz-ChA1 cells (gall bladder adenocarcinoma) were maintained in
CMRL-1066 medium (Life Technologies, Paisley, UK) containing
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10% FCS and penicillin/streptomycin (100 U/ml of each). Standard
tissue culture reagents were purchased from Life Technologies, Pais-
ley, UK.
The peptide [K]16-GGCRGDMFGCA was synthesised on a solid-
phase batch peptide synthesiser (Applied Biosystems, Foster City,
CA, USA) and disulphide-cyclised as described previously [14], the
peptides [K]16-GGCTHALWHTC, [K]16-GGCHLTWTAHC and
CTHALWHTC (all disulphide-cyclised) were synthesised by A⁄niti
Research Products, Exeter. The ability of each peptide to bind DNA
was analysed by addition of increasing amounts of peptide to a con-
stant amount of plasmid DNA, followed by electrophoresis on a 1%
agarose gel.
2.2. Biopanning
The random peptide phage display library Ph.D.-7 (New England
Biolabs, Beverly, MA, USA) was applied to 16HBE14o3 cells grown
in 6-well plates to con£uency. In this library seven amino acid-poly-
mers are displayed on the surface of M13-derived phages in fusion
with the phage coat protein pIII. 3 h prior to the biopanning proce-
dure the cell culture medium was replaced by serum-free MEM, fol-
lowed after 2 h by application of 1% bovine serum albumin (BSA) in
Dulbecco’s phosphate-bu¡ered saline (PBS), further incubation for 1 h
and washing with Tris-bu¡ered saline (TBS; 50 mM Tris^HCl, pH
7.5, and 150 mM NaCl). 2U1011 phages in 1 ml of TBS were applied
to a single well and allowed to bind to the cells at 4‡C for 60 min,
followed by washing away unspeci¢cally bound phages with TBS (10
washes) and elution of bound phages with 0.2 M glycine^HCl bu¡er,
pH 2.2. The eluate was neutralised with 1 M Tris^HCl, pH 9.1 (150
Wl/ml eluate), ampli¢ed in Escherichia coli ER2537 cells according to
the protocol provided by the manufacturer of the library and then re-
applied to the cells. In further panning rounds the phage binding time
was reduced to 15 min (second round) and 10 min (third round) to
increase the stringency of the procedure. Stringency was also increased
by using washing bu¡ers containing Tween-20 detergent (0.1% in the
second round, 0.2% in the third round). The phages were quanti¢ed
both after elution and ampli¢cation to enable the use of equal
amounts (2U1011 phages) in each round of biopanning. Phage eluates
were stored at 4‡C. After three rounds of phage selection 20 phages
were characterised by DNA sequencing on an ABI PRISM 377 DNA
sequencer using a BigDye Terminator cycle sequencing kit (Applied
Biosystems, Foster City, CA, USA).
2.3. Phage binding assays
Binding studies were performed using enzyme-linked immunosorb-
ent assays (ELISAs) on di¡erent human cells grown in 96-well plates
to con£uency. After blocking the plates with 1% BSA, 2-fold serial
dilutions of the phages (6U1010^4.9U108) were applied to the wells.
Phages were allowed to bind to the cells for 60 min at 4‡C. Unbound
phages were removed by washing the plates six times with a wash
bu¡er containing 0.2% Tween-20. An anti-M13 antibody conjugated
with horseradish peroxidase was then added to each well, followed by
addition of 2,2P-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)/
H2O2 solution after 1 h and measurement of the absorbance at 405
nm.
2.4. Confocal microscopy
Con£uent 16HBE14o3 cells grown on coverslips were transferred to
a damp box and incubated with 200 Wl of either FITC-labelled
THALWHT peptide or FITC-labelled HLTWTAH peptide (both at
concentrations of 50 Wg/ml) in prewarmed DMEM containing 10%
FCS for 60 min at 37‡C, 5% CO2. Following incubation the cells were
rinsed ¢ve times with PBS and ¢xed with 3% paraformaldehyde for
15 min. The coverslips were then rinsed and treated with 50 mM
NH4Cl in PBS for 10 min prior to a quick rinse with water, mounted
in Vectorshield (Vector, Burlingame, Canada) and sealed in para⁄n
wax. Cells were observed using a confocal microscope (Leica, Ger-
many).
2.5. Gene transfer experiments
The American ¢re£y luciferase gene under the control of a simian
virus 40 promoter and enhancer in the plasmid vector pGL3 (Prom-
ega, Madison, WI, USA) was used as reporter gene. Plasmid DNA
was puri¢ed from overnight cultures of transformed E. coli JM109
using an endotoxin extraction kit (Qiagen, Hilden, Germany). Cells
were seeded in tissue culture-treated 24-well plates at a density of
Fig. 1. Speci¢c binding of THALWHT-displaying bacteriophages to
the human bronchial epithelial cell line 16HBE14o3. a: The binding
of bacteriophages displaying the heptamer THALWHT was com-
pared with that of several control phages using ELISA. Two-fold
serial dilutions ranging from 6U1010 to 4.9U108 pfu were added to
con£uent 16HBE14o3 cells, followed by incubation for 1 h. After
careful washing cell-bound phages were quanti¢ed using an anti-
M13 antibody^horseradish peroxidase conjugate and measurement
of the absorbances at 405 nm. Each point represents the average
from six individual experiments. Error bars indicate the standard
deviations. F= phage displaying the heptamer THALWHT,
O= control phage displaying the heptamer VHPLPSF, E= control
phage displaying the heptamer IPACPSC, 7= control phage dis-
playing the dodecamer WKPPAYLSPSPT, a= control phage dis-
playing the dodecamer TPYFHSSLPARA. b: 6U1010 pfu of either
THALWHT- or IPACPSC-displaying phages were added to
16HBE14o3 (bronchial epithelium-derived), HTEo3 (tracheal epi-
thelium-derived), CaCo2 (colon carcinoma), HeLa (cervix epitheloid
carcinoma), HUH-7 (hepatoma), Mz-ChA1 (gall bladder epithelium-
derived) and SW480 (colon epithelium-derived) cells. The attached
phages were quanti¢ed using anti-M13 antibody^horseradish peroxi-
dase conjugate and measurement of the absorbances at 405 nm. The
average of three independent experiments is shown (16HBE14o3 :
n = 8). Error bars indicate the standard deviations.
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5U104/well and incubated until con£uent. Peptide^DNA and DNA^
LipofectAMINE complexes (24 Wg of LipofectAMINE/Wg of DNA)
were prepared in 50 Wl of serum-free OptiMEM medium (Life Tech-
nologies, Paisley, UK). The cells were washed and incubated in Opti-
MEM for 30 min at 37‡C prior to addition of the complexes and
further incubation for 4 h. The medium was then replaced by
DMEM containing 10% FCS supplemented with penicillin (100 U/
ml) and streptomycin (100 U/ml) and the incubation was continued
for an additional 44 h.
For competition experiments the cells were washed with OptiMEM
and pre-incubated with the peptide CTHALWHTC for 30 min prior
to the addition of peptide^DNA complexes. The peptide was added to
the wells in 500 Wl of OptiMEM medium at a ¢nal concentration of
100 WM. If chloroquine was used, this was added to the medium
20 min before the peptide^DNA complexes were applied. Luciferase
activity was determined after harvesting the cells in 200 Wl of reporter
lysis bu¡er (Promega, Madison, WI, USA) using the luciferase assay
kit from Promega and a Berthold luminometer. The relative light
units measured in 30 s were standardised per mg of total protein.
3. Results and discussion
Ligands of apically located receptors on human airway epi-
thelial cells have been tested as targeting moieties of gene
transfer systems by our group and others [11,17]. However,
ligands which bind more selectively and with higher a⁄nity to
the target cells are still required for most gene therapy appli-
cations. In our continuing search for such ligands we have
selected random peptides by screening a random heptamer
library in M13 bacteriophages on the human bronchial epi-
thelium-derived cell line 16HBE14o3. This cell line has been
described to develop the morphologic features of di¡erenti-
ated airway epithelial cells in vitro [27]. On cells forming a
con£uent layer the presence of microvilli on the apical surface
and of tight junctions separating apical and basolateral cell
membranes was con¢rmed by electron microscopy (data not
shown). Biopanning of the linear heptamer library Ph.D.-7
(New England Biolabs, Beverly, MA, USA) was performed
by three rounds of phage binding, acid-elution and ampli¢ca-
tion using a con£uent 16HBE14o3 cell layer in each round of
selection. During the biopanning steps the stringency of the
procedure was increased both by reducing the phage binding
time and by increasing the detergent concentration in the
washing bu¡er. After the third round of phage selection 20
phage clones were characterised by DNA sequencing.
Amongst those only the insert DNA sequence encoding the
peptide Thr-His-Ala-Leu-Trp-His-Thr (THALWHT) was
found repeatedly, in 15% of the phage clones analysed. Re-
covery of residual bound phages by lysis of the cells followed
by three rounds of phage binding, elution from the cell lysate
and ampli¢cation did not yield a consensus sequence,
although amino acid motifs with some similarity or partial
homology to THALWHT, for example the motif LWH,
were found. This fraction, however, is unlikely to represent
speci¢cally internalised phages, because phage display via
modi¢ed gene III proteins of the phage coat is limited by
the fact that a maximum of ¢ve copies of a peptide can be
displayed by any one phage, whereas binding of a larger num-
ber of identical peptides would be required for phagocytosis
allowing internalisation of particles as large as a phage.
Using ELISA the binding of the selectively enriched phage
to 16HBE14o3 cells was compared with that of several con-
trol phages across a range of concentrations between 4.9U108
and 6.3U1010 plaque forming units (pfu)/well. In this assay
the THALWHT-displaying phage bound markedly better
than any of the control phages to 16HBE14o3 cells, at all
concentrations tested (Fig. 1a). When the same assay was
performed on ¢ve other human cell lines derived from various
other tissues the binding of the THALWHT-displaying phage,
a control phage displaying the peptide IPACPSC (Fig. 1b)
and various other control phages (not shown) did not di¡er
signi¢cantly. This suggested a strong binding of the peptide
THALWHT speci¢cally to 16HBE14o3 cells via a receptor
abundant on these cells but not on non-airway derived cells.
To investigate whether the THALWHT motif would also bind
to airway epithelial cells di¡erent from 16HBE14o3 we per-
formed the same ELISA also on the human tracheal epithelial
cell line HTEo3 [28] and observed signi¢cantly better binding
of the THALWHT-displaying phage compared with the
IPACPSC-displaying phage (Fig. 1b) and various other con-
trol phages (not shown).
Con£uent 16HBE14o3 cells incubated with a synthetic £uo-
rescently labelled THALWHT peptide showed ¢ne vesicular
staining at the cell surface (Fig. 2a) and slightly larger vesicles
accumulated in a juxta-nuclear region of the cells in subse-
quent 1 Wm serial sections (Fig. 2b^d). In contrast,
16HBE14o3 cells exposed to a £uorescently labelled peptide
containing the same amino acids in a randomly generated
order (‘scrambled’ peptide HLTWTAH) did not exhibit vesic-
ular staining, but only a faint di¡use £uorescence signal as-
sumed to be at the cell surface (Fig. 2f). The staining pattern
of the THALWHT peptide is a typical feature of internalisa-
tion via endocytosis and suggests that binding of this peptide
to 16HBE14o3 cells is followed by its speci¢c internalisation.
As these data indicated that the peptide THALWHT may
be a high-a⁄nity ligand of receptors on human airway epi-
thelia we synthesised a peptide comprising disulphide-cyclised
CTHALWHTC as receptor-targeting domain and a DNA
binding moiety consisting of 16 lysine residues, together
with an appropriate control peptide containing the scrambled
sequence CHLTWTAHC. A cyclic head group was chosen,
because all our previous studies had shown that similar pep-
tides containing cyclic head groups were more e¡ective in me-
diating gene transfer into cells than their linear equivalents
[14,17]. With the synthetic peptide [K]16-GGCTHALWHTC
speci¢c gene delivery into 16HBE14o3 cells could be achieved.
Peptide^DNA complexes formed with one or two retardation
units of this peptide were found to deliver a luciferase reporter
gene more than one order of magnitude more e⁄ciently into
16HBE14o3 cells than complexes formed with identical
amounts of [K]16-GGCHLTWTAHC (Fig. 3). The relative
gene transfer e⁄ciency (standardised as percentage of Lipo-
fectAMINE-mediated transfection on these cells) was signi¢-
cantly higher than that achieved with any of the systems for
integrin-mediated gene transfer developed in our laboratory
[14,17]. In di¡erent experiments the relative e⁄ciencies of
[K]16-GGCTHALWHTC-mediated gene delivery varied be-
tween 6 and 12% of the respective LipofectAMINE control,
in comparison with about 1% following gene transfer by the
RGD-containing peptide [K]16-GGCRGDMFGCA. Gene
transfer assays performed in parallel on 16HBE14o3 cells
and on the non-airway-derived epithelial cell lines CaCo2
and HeLa con¢rmed that the peptide [K]16-
GGCTHALWHTC enables selective gene transfer to human
airway epithelial cells (Fig. 3, insert), whereas for [K]16-
GGCRGDMFGCA which was used as a control peptide in
these experiments no signi¢cant di¡erences between the three
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cell lines were seen (not shown). The speci¢city of gene deliv-
ery by [K]16-GGCTHALWHTC was further demonstrated
in competition assays using an excess of the peptide
CTHALWHTC. Reporter gene expression following [K]16-
GGCTHALWHTC-mediated gene delivery was 5-fold re-
duced when the gene transfer was performed in the presence
of free CTHALWHTC, whereas no signi¢cant e¡ect of this
peptide on [K]16-GGCRGDMFGCA- or [K]16-GGCHLTW-
TAHC-mediated gene transfer could be observed (Fig. 4).
Competition with free CTHALWHTC thus reduced the bind-
ing of the corresponding peptide^DNA complexes to the tar-
get cells, thereby decreasing the number of complexes which
are internalised unspeci¢cally due to the charge of the peptide.
In summary, the gene transfer experiments demonstrate that
THALWHT is the targeting motif which can direct the trans-
fection of the corresponding peptide^DNA complex.
As our assay standard, the cationic liposome LipofectAM-
INE, gave on average 12-fold higher reporter gene expression
values, we tried to enhance gene delivery by addition of the
lysosomolytic agent chloroquine. This approach allowed us to
increase the gene transfer e⁄cacy by one order of magnitude
(Fig. 5). Together with the confocal microscopy data this
result strongly indicates that the peptide^DNA complexes
are taken up by endocytosis after binding to the cells and
that their release from the endosomes is an important factor
determining the gene expression e⁄ciency.
Peptide libraries in bacteriophages consisting of fully ran-
domised peptides have proven useful for the identi¢cation of
several interesting targeting ligands [8,29^32], however, a pep-
tide identi¢ed in a particular biopanning experiment does not
necessarily resemble a natural ligand of the proposed receptor.
The biopanning procedure iteratively selects those peptides
which bind best to the target under the panning conditions
in vitro, which may di¡er signi¢cantly from the in vivo sit-
uation. For peptides binding to large surfaces of a protein or
to discontinuous regions of the primary sequence, the selected
motifs are therefore not likely to correspond exactly to the
natural binding site. The symmetry of the amino acid motif
identi¢ed here may suggest that the tripeptide Ala-Leu-Trp
(ALW) represents the active binding site, whereas the threo-
nine and histidine residues may be necessary to ful¢l confor-
mational requirements for binding to the receptor. In any
natural ligand of the proposed receptor, however, the binding
site may be surrounded by di¡erent amino acids. We have
been unable to ¢nd a protein containing a THALWHT motif
in the accessible databases, thus the proposed receptor and its
natural ligands still remain to be identi¢ed.
To answer the question whether the THALWHT motif
Fig. 3. Reporter gene delivery using a cyclic [K]16-
GGCTHALWHTC peptide. Peptide^DNA complexes containing
one, two or four retardation units of [K]16-GGCTHALWHTC
(black bars) or the ‘scrambled’ peptide [K]16-GGCHLTWTAHC
(white bars) (one retardation unit corresponding to the amount of
peptide required for complete retardation of the electrophoretic mo-
bility of 1 Wg of DNA) or pGL3 DNA without peptide (grey bar)
were incubated with 16HBE14o3 cells on 24-well dishes for 4 h at
37‡C. Following further incubation in fresh medium for an addi-
tional 44 h, luciferase activity in the cell lysates was determined.
Data are presented as percentages of those obtained with Lipofect-
AMINE in the same experiment. Each column represents the aver-
age result of three experiments each performed in sextuplets. Error
bars indicate the standard deviations. The insert shows an independ-
ent experiment using two retardation units of [K]16-GGCTHALW-
HTC on 16HBE14o3, CaCo2 and HeLa cells.
Fig. 4. Competitive inhibition of [K]16-GGCTHALWHTC-mediated
gene delivery by free CTHALWHTC. Transfection of pGL3 DNA
into 16HBE14o3 cells using di¡erent synthetic peptides was per-
formed as described above, either in the presence or in the absence
of the peptide CTHALWHTC. The cells were pre-incubated with
the free peptide at a concentration of 100 WM for 30 min prior to
the addition of peptide^DNA complexes. The graph shows lucifer-
ase reporter gene expression standardised against protein concentra-
tion in the absence (black bars) or presence (white bars) of the pep-
tide CTHALWHTC. Data are presented as percentages of those
obtained with LipofectAMINE in the same experiment. Each col-
umn represents the average result from sextuplet wells. Error bars
indicate the standard deviations.
Fig. 2. Speci¢c internalisation of THALWHT peptides into 16HBE14o3 cells. Con£uent 16HBE14o3 cells were incubated with either FITC-la-
belled THALWHT (a^e) or FITC-labelled ‘scrambled’ peptide HLTWTAH (f and g) at equal concentrations for 60 min. Representative 1 Wm
confocal optical serial sections starting near the cell surface (a) down through the cells (b^d) are shown. Apart from a slight signal believed to
be at the cell surface no cell-associated scrambled peptide was detectable (f). The same ¢elds are also shown under phase contrast (e and g).
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would allow selective gene delivery into human airway epithe-
lial cells and thus be suitable for incorporation into various
gene therapy vectors, we primarily synthesised a synthetic
peptide comprising this motif and a cationic DNA binding
moiety. This peptide vector enabled e⁄cient targeted gene
delivery into 16HBE14o3 cells suggesting that the
THALWHT motif may allow selective gene transfer into hu-
man airway epithelia in vivo. As it is well known that di¡er-
entiated airway epithelial cells are much less susceptible to
gene transfer by any non-viral system [33], we have begun
to generate a re-targeted adenoviral vector by incorporating
THALWHT into the coat of the virus.
Recent work by Romanczuk et al. [25] identi¢ed a number
of non-related peptides by screening a dodecamer phage dis-
play library on other human airway epithelial cells and dem-
onstrated that coupling of one of these peptides to adenoviral
vectors improved adenoviral infection of such cells signi¢-
cantly. Any epithelial cell line only partially reproduces the
repertoire of receptors displayed on the surface of epithelia in
vivo and the use of detergent in our panning procedure may
have solubilised part of the receptors displayed on
16HBE14o3 cells. This, in addition to the use of di¡erent
peptide libraries, may explain the di¡erences between the pep-
tides found. Thus, direct comparison of the binding of the
peptides identi¢ed by Romanczuk et al. and the THALWHT
peptide to the cells of interest will be required to determine
the usefulness of each peptide for a particular gene therapy
application. We will continue this study by evaluating the
THALWHT peptide on primary airway cells and by investi-
gating whether its putative receptor would be located apically
on airway epithelial cells in vivo and thus be accessible for
gene therapy vectors delivered into the airways. Furthermore,
we will explore the possibilities to improve the release of our
peptide from the endosomes by addition of endosomolytic
peptides [34] instead of chloroquine. The suitability of the
THALWHT motif demonstrated so far may be exploitable
broadly, e.g. for the targeting of liposomes [35,36] or the re-
targeting of adenoviral and retroviral vectors [20,24^26].
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